| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |